The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.


Updates from The Motley Fool

Latest updates on AstraZeneca from Fool.com.  The Fool has written over 600 articles on AstraZeneca.
3 High-Yield International Stocks

Are you looking for income and willing to invest outside the U.S.? Here's why you should consider...

3 Value Stocks for Every Investor

Who doesn't like a good value? Here are several stocks that offer a little something for almost e...



Stock Performance

View Interactive AZN Charts
Sponsored by

Key Data Points

Primary metrics and data points about AstraZeneca.
Current Price: $34.99
Prev Close: $35.08
Open: $35.04
Bid: $34.99
Ask: $35.00
Day's Range: $34.94 - $35.14
52wk Range: $26.51 - $35.92
Volume: 1,284,920
Avg Vol 3,040,087
Market Cap: $89B
P/E (ttm): 15.73
EPS (ttm): $0.00
Div & Yield: $0.90 (3.9%)

Company Rating

What our community thinks about AstraZeneca.
CAPS Rating 4 out of 5
 
705 Outperform
42 Underperform
CAPS All Stars
 
140 Outperform
7 Underperform

How do you think AstraZeneca will perform against the market?



You pick for AstraZeneca is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Pascal Soriot, CEO

87% Approve

Based on 537 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AstraZeneca.

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers